Abstract: The invention relates to a secondary part (2, 3) of a linear electrical machine (5), wherein the secondary part (2, 3) has permanent magnets (11) and a mount (13). The secondary part (2, 3) has spacer elements (9), wherein an installation height of the secondary part (2, 3) is also determined by means of the spacer elements (9). Tolerances of the installation height can be maintained more easily by means of the spacer elements. In a method for manufacturing a secondary part (2, 3) of a linear electrical machine (5), the spacer elements (9) are cast together with the mount (13) on which the permanent magnets (9) are arranged such that the permanent magnets (9) are embedded in the casting compound (15) and the casting compound (15) forms the surface of the secondary part (2, 3) in the region of the permanent magnets (11), wherein the spacer elements (9) protrude out of the casting compound (15) such that part of the surface of the secondary part (2, 3) is also formed by the spacer elements (9).

Abstract: The invention relates to a secondary part (2, 3) of a linear electrical machine (5), wherein the secondary part (2, 3) has permanent magnets (11) and a mount (13). The secondary part (2, 3) has spacer elements (9), wherein an installation height of the secondary part (2, 3) is also determined by means of the spacer elements (9). Tolerances of the installation height can be maintained more easily by means of the spacer elements. In a method for manufacturing a secondary part (2, 3) of a linear electrical machine (5), the spacer elements (9) are cast together with the mount (13) on which the permanent magnets (9) are arranged such that the permanent magnets (9) are embedded in the casting compound (15) and the casting compound (15) forms the surface of the secondary part (2, 3) in the region of the permanent magnets (11), wherein the spacer elements (9) protrude out of the casting compound (15) such that part of the surface of the secondary part (2, 3) is also formed by the spacer elements (9).

Abstract: The present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of recombinant bone morphogenic proteins (rBMPs) and its use in therapy, especially in the treatment of orthopaedic and dental patients. Specifically, the present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of at least two rBMPs or their monomers or mutants in a suitable carrier system.

Abstract: The present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of recombinant bone morphogenic proteins (rBMPs) and its use in therapy, especially in the treatment of orthopaedic and dental patients. Specifically, the present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of at least two rBMPs or their monomers or mutants in a suitable carrier system.

Abstract: The present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of recombinant bone morphogenic proteins (rBMPs) and its use in therapy, especially in the treatment of orthopaedic and dental patients. Specifically, the present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of at least two rBMPs or their monomers or mutants in a suitable carrier system.

Abstract: The invention relates to a secondary part for a motor, comprising at least one carrier element (10) and several permanent magnets (12) and a cast body made of plastic, whereby the permanent magnets (12) are cast therein. According to the invention, the cast body is made of thermoplastic material. According to the inventive method, the cast body is produced in a molding tool (110, 130) of an injection molding machine. Positioning elements (140) are provided in the molding tool (130) in order to fix the permanent magnets (12) on the carrier element (10). The positioning elements are withdrawn from the cavity of the molding tool after the first filling phase. The thus resulting voids are filled in a second filling phase.

Abstract: A novel polymer composition is provided which includes a base material including a biodegradable polymer or copolymer, and a copolymer additive including one or more monomers imparting a tensile strength to the polymer composition at room temperature that is lower than a tensile strength at room temperature for the base material.

Abstract: A surgical tissue fixation system is described, including: (1) a bioabsorbable tissue fixation plate having optionally a plurality of through-holes arranged in alternating relation along the plate; (2) bioabsorbable fasteners adapted for insertion into the through-holes to secure the plate to underlying bodily tissue or bone; and (3) an installation instrument which triggers (strikes or shoots) fasteners one after one, in rapid succession, into the through-holes made through the plate and into the underlying bodily tissue or bone, which also optionally includes drillholes.

Abstract: A surgical tissue fixation system is described, including: (1) a bioabsorbable tissue fixation plate having optionally a plurality of through-holes arranged in alternating relation along the plate; (2) bioabsorbable fasteners adapted for insertion into the through-holes to secure the plate to underlying bodily tissue or bone; and (3) an installation instrument which triggers (strikes or shoots) fasteners one after one, in rapid succession, into the through-holes made through the plate and into the underlying bodily tissue or bone, which also optionally includes drillholes.

Abstract: The present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of recombinant bone morphogenic proteins (rBMPs) and its use in therapy, especially in the treatment of orthopaedic and dental patients. Specifically, the present invention relates to a pharmaceutical composition containing a mixture of stable folding variants of at least two rBMPs or their monomers or mutants in a suitable carrier system.

Abstract: A novel polymer composition is provided which includes a base material including a biodegradable polymer or copolymer, and a copolymer additive including one or more monomers imparting a tensile strength to the polymer composition at room temperature that is lower than a tensile strength at room temperature for the base material.